Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma versus standard plasma in hospitalized non-ICU adults with COVID-19
NL-OMON49946Phase 3Not yet recruiting
- Sponsor
- Leiden University Medical Center
- Start
- May 2020
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Convalescent plasma with Standard plasma control (2 arms). Primary endpoint: Primary ordinal clinical outcome. Planned start May 2020; status: not yet recruiting.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)Fresh Frozen Plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON49946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49946.